Health care utilization and costs of patients with ME/CFS in Norway, a retrospective registry study

Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic illness without any known cause or treatment. Diagnostic processes are typically long, and with no established treatment option available, little is known about patients’ total health care utilization and costs. This study analyses health care utilization and costs among patients with ME/CFS in Norway and examines whether they differ from those observed in selected comparison groups. Methods We conducted a retrospective, population-based registry study using linked individual-level data from Norwegian national registries. Information on health care utilization, including hospital treatments, GP contacts and primary health care was collected and linked from national registries. Comparison groups included a random sample of the population and patients diagnosed with Lyme disease, breast cancer or fibromyalgia. Costs were measured as total hospital costs, while costs from general practitioners (GP) and primary care utilization were estimated based on GP tariff, estimated out of pocket payment to GP and national averages for each provided primary care service. Methods included descriptive statistics and regression of costs. Results Patients with ME/CFS utilize health care services less than other comparable diagnoses, but more than a random sample of the population. Health care costs among patients with ME/CFS were almost three times those observed in the random population sample, but were lower than the costs among patients with breast cancer. Conclusions Health care use and costs were particularly high for hospital treatments, while at the same time no clear treatment option is available. Greater attention should be paid to comorbidities among patients with ME/CFS. Further research is needed to determine whether some of their care could be provided more appropriately at other levels of the health care system rather than in hospitals.

Authors

Institutions

Publication Details

Journal
BMC Health Services Research
Published
2026-10-30
DOI
https://doi.org/10.1186/s12913-026-16008-6
Primary Topic
Fibromyalgia and Chronic Fatigue Syndrome Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health care utilization and costs of patients with ME/CFS in Norway, a retrospective registry study

Kjartan Sarheim Anthun, Line Maria Haugen Melby, Thomas Halvorsen
BMC Health Services Research
Fibromyalgia and Chronic Fatigue Syndrome Research
article

Health care utilization and costs of patients with ME/CFS in Norway, a retrospective registry study

Kjartan Sarheim Anthun, Line Maria Haugen Melby, Thomas Halvorsen
article en

Abstract

Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic illness without any known cause or treatment. Diagnostic processes are typically long, and with no established treatment option available, little is known about patients’ total health care utilization and costs. This study analyses health care utilization and costs among patients with ME/CFS in Norway and examines whether they differ from those observed in selected comparison groups. Methods We conducted a retrospective, population-based registry study using linked individual-level data from Norwegian national registries. Information on health care utilization, including hospital treatments, GP contacts and primary health care was collected and linked from national registries. Comparison groups included a random sample of the population and patients diagnosed with Lyme disease, breast cancer or fibromyalgia. Costs were measured as total hospital costs, while costs from general practitioners (GP) and primary care utilization were estimated based on GP tariff, estimated out of pocket payment to GP and national averages for each provided primary care service. Methods included descriptive statistics and regression of costs. Results Patients with ME/CFS utilize health care services less than other comparable diagnoses, but more than a random sample of the population. Health care costs among patients with ME/CFS were almost three times those observed in the random population sample, but were lower than the costs among patients with breast cancer. Conclusions Health care use and costs were particularly high for hospital treatments, while at the same time no clear treatment option is available. Greater attention should be paid to comorbidities among patients with ME/CFS. Further research is needed to determine whether some of their care could be provided more appropriately at other levels of the health care system rather than in hospitals.

BMC Health Services Research
SINTEF (NO), Norwegian University of Science and Technology (NO), Trondheim Kommune (NO), SINTEF Digital (NO)
SINTEF Industri
Good health and well-being
Openalex Percentile: Top 12%
Fibromyalgia and Chronic Fatigue Syndrome Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon